Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Residual Antimicrobial Efficacy of 4% Chlorhexidine Gluconate
NCT04654182Phase 4Completed
- Sponsor
- Mölnlycke Health Care
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of chlorhexidine in bacterial infection, sponsored by Mölnlycke Health Care. Primary endpoints: Bacterial counts at 6 hours and Bacterial counts at 12 hours. Started Nov 2020; status: completed.
02
Drugs
chlorhexidine
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04654182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04654182.